Measurement of Hepatic Drug-metabolizing Enxyme Activity in Man. Comparison of Three Different Assays

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1980 Apr 1

PMID 6105079

Citations 6

Authors

E A Sotaniemi

R O Pelkonen

M Puukka

Affiliations

Soon will be listed here.

Citing Articles

Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.

Caparrotta T, Antoine D, Dear J Eur J Clin Pharmacol. 2017; 74(2):147-160.

PMID: 29067481 PMC: 5765191. DOI: 10.1007/s00228-017-2356-6.

Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity : A double-blind controlled trial of selenium supplementation.

Luoma P, Korpela H, Sotaniemi E, Kumpulainen J Biol Trace Elem Res. 2013; 8(2):113-21.

PMID: 24257871 DOI: 10.1007/BF02917465.

Use of over-the-counter analgesics in patients with chronic liver disease: physicians' recommendations.

Rossi S, Assis D, Awsare M, Brunner M, Skole K, Rai J Drug Saf. 2008; 31(3):261-70.

PMID: 18302450 DOI: 10.2165/00002018-200831030-00007.

Saliva and plasma clearance of antipyrine as reflectors of liver function.

Luoma P, Sotaniemi E Eur J Drug Metab Pharmacokinet. 1981; 6(4):261-4.

PMID: 7333326 DOI: 10.1007/BF03189523.

Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.

Luoma P, Sotaniemi E, Pelkonen R, Arranto A, Ehnholm C Eur J Clin Pharmacol. 1982; 23(3):275-82.

PMID: 7173298 DOI: 10.1007/BF00547568.

References

Smith S, Rawlins M . Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol. Eur J Clin Pharmacol. 1974; 7(1):71-5. DOI: 10.1007/BF00614394. View

. Editorial: Drug metabolism in disease. Lancet. 1974; 1(7861):790-1. View

Sotaniemi E, Medzihradsky F, Eliasson G . Glucaric acid as an indicator of use of enzyme-inducing drugs. Clin Pharmacol Ther. 1974; 15(4):417-23. DOI: 10.1002/cpt1974154417. View

Kapitulnik J, Popper P, Conney A . Comparative metabolism of benzo[a]pyrene and drugs in human liver. Clin Pharmacol Ther. 1977; 21(2):166-76. DOI: 10.1002/cpt1977212166. View

Davis M, Simmons C, Dordoni B, Williams R . Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction. Br J Clin Pharmacol. 2012; 1(3):253-7. PMC: 1402553. DOI: 10.1111/j.1365-2125.1974.tb00246.x. View

Sotaniemi E, Hynnynen T, Ahlqvist J, Ahokas J, Puoskari U, Pelkonen I . Effects of medroxyprogesterone on the liver function and drug metabolism of patients with primary biliary cirrhosis and chronic active hepatitis. J Med. 1978; 9(2):117-28. View

Marsh C, Carr A . CHANGES IN ENZYME ACTIVITY, RELATED TO D-GLUCARIC ACID SYNTHESIS, WITH AGE, PREGNANCY AND MALIGNANCY. Clin Sci. 1965; 28:209-17. View

Hunter J, Maxwell J, Carrella M, Stewart D, Williams R . Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man. Lancet. 1971; 1(7699):572-5. DOI: 10.1016/s0140-6736(71)91166-4. View

Cunningham J, Evans D . Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration. Eur J Clin Pharmacol. 1974; 7(5):387-91. DOI: 10.1007/BF00558212. View

10.

Branch R, Herbert C, Read A . Determinants of serum antipyrine half-lives in patients with liver disease. Gut. 1973; 14(7):569-73. PMC: 1412804. DOI: 10.1136/gut.14.7.569. View

11.

Hunter J . Enzyme induction and medical treatment. J R Coll Physicians Lond. 1974; 8(2):163-74. PMC: 5366562. View

12.

Alvares A, Schilling G, Levin W, Kuntzman R, Brand L, Mark L . Cytochromes P-450 and b5 in human liver microsomes. Clin Pharmacol Ther. 1969; 10(5):655-9. DOI: 10.1002/cpt1969105655. View

13.

Greim H, Schenkman J, Klotzbucher M, Remmer H . The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. Biochim Biophys Acta. 1970; 201(1):20-5. DOI: 10.1016/0304-4165(70)90005-x. View

14.

Mawer G, MILLER N, Turnberg L . Metabolism of amylobarbitone in patients with chronic liver disease. Br J Pharmacol. 1972; 44(3):549-60. PMC: 1665818. DOI: 10.1111/j.1476-5381.1972.tb07292.x. View

15.

Ahlqvist J . Transverse mounting of ribbons on groups of slides for comparing different stains in adjacent sections. Stain Technol. 1970; 45(1):38-9. View

16.

Latham A, Turner P, Franklin C, Maclay W . Phenobarbitone-induced urinary excretions of D-glucaric acid and 6beta-hydroxycortisol in man. Can J Physiol Pharmacol. 1976; 54(5):778-82. DOI: 10.1139/y76-108. View

17.

Stevenson I . Factors influencing antipyrine elimination. Br J Clin Pharmacol. 1977; 4(3):261-5. PMC: 1429089. DOI: 10.1111/j.1365-2125.1977.tb00710.x. View

18.

Klotz U, McHorse T, Wilkinson G, Schenker S . The effect of cirrhosis on the disposition and elimination of meperidine in man. Clin Pharmacol Ther. 1974; 16(4):667-75. DOI: 10.1002/cpt1974164667. View

19.

Lecamwasam D, Franklin C, Turner P . Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. Br J Clin Pharmacol. 1975; 2(3):257-62. PMC: 1402570. DOI: 10.1111/j.1365-2125.1975.tb01584.x. View

20.

Pelkonen O, Kaltiala E, LARMI T, KARKI N . Comparison of activities of drug-metabolizing enzymes in human fetal and adult livers. Clin Pharmacol Ther. 1973; 14(5):840-6. DOI: 10.1002/cpt1973145840. View